The formation of the fields with a more dynamic growth, within the tumor areas of an increased RCAS1 expression, suggests the practical implementation of the concept that suppressive microenvironment profile facilitated by RCAS1 molecules, attenuates the immune system inhibition of tumor growth. The gene discussed is EBAG9; the disease is neoplasm.